The future of prenatal diagnosis: karyotype, microarray or both? Technical and ethical considerations.

Abstract

Prenatal diagnosis is now offered to high-risk pregnancies, including advanced maternal age, ultrasound anomalies and positive Down's syndrome screening, and karyotype on cultured fetal material is the test of choice to screen these pregnancies. However, microscope analysis can only detect gross chromosome abnormalities, highlighting the need for more… (More)
DOI: 10.1586/epr.13.9

Topics

Cite this paper

@article{Novelli2013TheFO, title={The future of prenatal diagnosis: karyotype, microarray or both? Technical and ethical considerations.}, author={Antonio Novelli and Pietro Cavalli and Laura Bernardini}, journal={Expert review of proteomics}, year={2013}, volume={10 2}, pages={131-4} }